Selank

WELL RESEARCHED

Anxiolytic peptide | Synthetic tuftsin analog

By the INFOPEPTIDOS editorial team · content based on scientific literature.

Updated: August 2026.

Selank — Anxiolytic peptide derived from tuftsin. It is mainly researched for anxiety, stress and mood. Typical dose: 250–500 mcg per day, intranasal route. Not FDA-approved.
Typical dose
250-500 µg
1-3 times a day
Route
Nasal
Intranasal (one spray per nostril)
Cycle
2-4 weeks
Typical duration
Storage
2-8 °C
Refrigerated

Key points

Technical data: Molecular formula C33H57N11O9 · Molecular weight 751.9 g/mol. Source: PubChem.

Overview

What is Selank?

Selank is a synthetic heptapeptide analog of tuftsin, developed in Russia and studied for its anxiolytic (anti-anxiety) and nootropic effects, without the sedation or dependence of classic anxiolytics. It works by modulating the GABA system and increasing BDNF levels. It is not FDA-approved.

Key benefits

Anxiety reduction without sedation, improved mood and mental clarity, a nootropic effect and immune modulation, with a good safety profile.

Mechanism of action

It modulates the GABAergic system and serotonin and dopamine levels, stabilizes enkephalins (inhibiting their breakdown) and increases BDNF. Its intranasal administration helps it reach the brain quickly.

Quick start guide

Typical dose
250-500 µg per day
How often
1-3 times a day
Where to apply
Intranasal, one spray in each nostril
Best time
Spread throughout the day as needed
Effects timeline
Anxiolytic effects in 30-60 minutes; full benefits in 1-2 weeks
Storage
Refrigerate at 2-8 °C; protect from light
Cycle length
2-4 weeks
Break between
2-4 weeks

Dosing protocol

PhaseDoseRouteFrequency
Standard250–500 mcgIntranasal1–2 times/day (in cycles)

The specific dose must be assessed by a healthcare professional.

🧮 Calculate your exact syringe dose →

Semax vs Selank

 SemaxSelank
Main effectCognition and focusAnxiolysis and calm
MechanismBDNF and dopamineTuftsin, GABA/serotonin
RouteIntranasalIntranasal
FDA statusNot approvedNot approved

⚠️ Who should NOT use it

What to expect

Side effects & safety

Frequently asked questions

What is Selank?

Selank is a synthetic heptapeptide analog of tuftsin, developed in Russia and studied for its anxiolytic and nootropic effects.

What is Selank researched for?

It is studied for anxiety, mood, mental clarity and immune system modulation.

How does Selank work?

It modulates the GABA system and serotonin and dopamine levels, stabilizes enkephalins and increases BDNF.

How long does Selank take to work?

Anxiolytic effects are described in 30-60 minutes and full benefits in 1-2 weeks.

What is the usual Selank dose?

Most commonly 250-500 µg per day. The schedule should be assessed by a professional.

How is Selank administered?

Intranasally, as a spray in each nostril.

How is Selank stored?

Refrigerated and protected from light. See the storage guide.

What are the side effects of Selank?

It is described as well tolerated; the most common is mild nasal irritation. It does not cause sedation or dependence like classic anxiolytics.

Which peptides is Selank combined with?

The most cited combination is Selank with Semax, aimed at anxiety and cognitive function.

Is Selank approved?

It is not FDA-approved; in Russia it is used in the context of anxiety.

What is the difference between Selank and Semax?

Selank is more anxiolytic (anxiety), while Semax is more nootropic (cognition).

Research areas

Related peptides

Related articles

Related topics

Summary

What it is: Anxiolytic heptapeptide analog of tuftsin.

How it is researched: Intranasal, 250-500 µg per day.

Key features: Reduces anxiety without sedation; modulates GABA. Not FDA-approved.

Related peptides: Semax, Epitalon and MOTS-c.

References

  1. Panikratova YR et al. (2020). Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. PubMed · DOI
  2. Medvedev VE et al. (2014). [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders]. Zh Nevrol Psikhiatr Im S S Korsakova. PubMed
  3. Kasian A et al. (2017). Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. PubMed · DOI
  4. Filatova E et al. (2017). GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. Front Pharmacol. PubMed · DOI

Studies compiled from PubMed for informational purposes; many are preclinical or research-stage and do not constitute medical advice.